Ventricular Tachycardia clinical trials at UCSD

1 in progress, 0 open to eligible people

Showing trials for

  • FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study

    Sorry, in progress, not accepting new patients

    This clinical investigation is intended to demonstrate the safety and effectiveness of ventricular ablation therapy using the FlexAbility Sensor Enabled Ablation Catheter in patients with drug-refractory monomorphic ventricular tachycardia in whom ventricular tachycardia recurs despite antiarrhythmic drug therapy or when antiarrhythmic drugs are not tolerated or desired.

    San Diego, California and other locations

Last updated: